Literature DB >> 31856485

Commentary: Enterobacter endophthalmitis: Clinical settings, susceptibility profile, and management outcomes across two decades.

Chitaranjan Mishra1, Kim Ramasamy1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 31856485      PMCID: PMC6951177          DOI: 10.4103/ijo.IJO_1527_19

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
The trends in incidence, clinical features, antimicrobial susceptibility, or the management outcomes for a given organism-related endophthalmitis needs to be studied over a longer period of time, especially to verify the need for a change in the prevalent treatment approaches and prognostication.[12] We congratulate the authors for their current work to carry forward the study on the clinical settings, susceptibility profile, and management outcomes of Enterobacter endophthalmitis over a considerably long duration. Open globe injury remains the most common etiology of Enterobacter endophthalmitis in both the consecutive studies done by the authors.[34] Median presentation remains for 4 days emphasizing the need for more robust gram negative work-up, especially for cases presenting early post trauma or following ocular procedures. Though the final outcome remains unfavourable, the results of the scientific analysis of this data helps the peer ophthalmologists to be aware about the seriousness of the condition, need for proper counselling of the patient, and possibly try to explore alternate effective antibiotic regimens. However, there are certain points to be commented in this study. First, it would have been better to report the resistance pattern in particular, since the susceptibility has already been reported in the previous study. The authors have mentioned about three cases of multidrug resistance in the discussion. Second, it would have been more interesting if the authors compared the minimum inhibitory concentration (MIC) of various antibiotics and compare it with their own previous study (if data were available). The present study by Dave et al (Table 2 showing antimicrobial susceptibilities for the antibiotics tested) gives us a false sense of security of mild increase in antibiotic susceptibility.[4] Third, since the outcome is poor in the current study and their previous study published in 2012, it would have been better if they included other drugs e.g., imipenem, piperacillin, and tazobactam in the management of their cases.[356] Fourth, it would have been good to specify about the absence of any post pars plana vitrectomy procedure related Enterobacter endophthalmitis cases in this series. Furthermore, the authors did not find any case following anti-VEGF injections. A single centre large-scale retrospective case series from South India has recently found that gram negative bacilli were the most commonly found organisms in endophthalmitis following pars plana vitrectomy.[7] Similar studies needs to be carried out over a longer duration to see the trends in incidence, clinical features, antimicrobial susceptibility, and the management outcomes, especially in endophthalmitis cases where the prognosis remains guarded and the treatment remains largely empirical. Open globe injury cases should be managed more meticulously, not only for trauma related structural damage, but also for poly microbial infections making the prognosis more unfavourable. There should be studies to find out more effective antibiotics in Enterobacter endophthalmitis cases, since the regular empirical antibiotics remains largely resistant.
  7 in total

1.  Coagulase-negative Staphylococcus isolates causing endophthalmitis: Changing patterns of vancomycin susceptibilities.

Authors:  Jack D Stringham; Nidhi Relhan; Nicolas A Yannuzzi; Darlene Miller; Harry W Flynn
Journal:  J Cataract Refract Surg       Date:  2019-03       Impact factor: 3.351

2.  Enterobacter endophthalmitis: clinicomicrobiologic profile and outcomes.

Authors:  Avinash Pathengay; Hemant S Trehan; Annie Mathai; Subhadra Jalali; Ajit B Majji; Manmath K Das; Savitri Sharma; Taraprasad Das
Journal:  Retina       Date:  2012-03       Impact factor: 4.256

3.  Microbiological Isolates and Antibiotic Susceptibilities: A 10-Year Review of Culture-Proven Endophthalmitis Cases.

Authors:  Chunhong Liu; Jian Ji; Shengjie Li; Zhujian Wang; Li Tang; Wenjun Cao; Xinghuai Sun
Journal:  Curr Eye Res       Date:  2016-06-27       Impact factor: 2.424

4.  Outbreak of multidrug-resistant acute postoperative endophthalmitis due to Enterobacter aerogenes.

Authors:  Shailaja S Bhat; Vivekanand Undrakonda; Chiranjay Mukhopadhyay; Prachi Vikramsinh Parmar
Journal:  Ocul Immunol Inflamm       Date:  2013-09-24       Impact factor: 3.070

5.  Enterobacter endophthalmitis: Clinical settings, susceptibility profile, and management outcomes across two decades.

Authors:  Vivek Pravin Dave; Avinash Pathengay; Shashwat Behera; Joveeta Joseph; Savitri Sharma; Rajeev Reddy Pappuru; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

6.  Enterobacter endophthalmitis: treatment with intravitreal tazobactam - piperacillin.

Authors:  Trehan Hemant Singh; Avinash Pathengay; Taraprasad Das; Savitri Sharma
Journal:  Indian J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.848

7.  Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital.

Authors:  Muna Bhende; Rajiv Raman; Mukesh Jain; Pratik K Shah; Tarun Sharma; Lingam Gopal; Pramod S Bhende; Sangeetha Srinivasan; Malathi Jambulingam
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.